Intermediate Effect Variants in HCM: Integration into Clinical Practice and Family Screening

R Roddy Walsh (Cardiovascular and Genomics Research Institute, City St. George’s, University of London, London, UK (R.W.).) P Pablo Garcia-Pavia (Department of Cardiology, Hospital Universitario Puerta de Hierro, Instituto de Investigación Sanitaria Puerta de Hierro–Segovia de Arana, Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares, and Centro Nacional de Investigaciones Cardiovasculares, Madrid) J Juan Pablo Ochoa (Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain (N.R.-L., J.P.O., A.G.-Á., P.G.-P.).)

Article Details

Journal Circulation
Volume / Issue Vol. 153, Issue 18
Published May 05, 2026
Pages 1347-1349
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (3)

R

Roddy Walsh

Cardiovascular and Genomics Research Institute, City St. George’s, University of London, London, UK (R.W.).

P

Pablo Garcia-Pavia

Department of Cardiology, Hospital Universitario Puerta de Hierro, Instituto de Investigación Sanitaria Puerta de Hierro–Segovia de Arana, Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares, and Centro Nacional de Investigaciones Cardiovasculares, Madrid

J

Juan Pablo Ochoa

Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain (N.R.-L., J.P.O., A.G.-Á., P.G.-P.).